RenovoRx surges on social media chatter, pancreatic cancer presentation

RenovoRx

10/11/2021 14:57

** Shares of biopharma co  RNXT.O  up 110% at $11.29    
    ** RNXT is second-most trending ticker on investor-focused
social media site stocktwits.com, with message vols rising
489.61%
    ** More than 36.5 mln shares traded vs. 10-DMA vol of 83,935
    ** Co's principal investigator presented data on Tuesday on
use of intra-arterial chemotherapy in its ongoing clinical trial
as potential treatment for pancreatic cancer; stock had risen
1.3% by close on Tuesday  urn:newsml:reuters.com:*:nBw9z0Px9a
    ** Both brokerages covering stock rate it "buy" 
    ** Co was among top premarket movers
    ** Stock has risen 24.7% since its debut in August,
including session's gains

 (Reporting by Bansari Mayur Kamdar)
 ((BansariMayur.Kamdar@thomsonreuters.com;))